| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 397 (10285), 1637-1645, 2021 | 473* | 2021 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ... Medrxiv, 2021.06. 15.21258542, 2021 | 373* | 2021 |
| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): preliminary results of a randomised, controlled, open-label, platform trial PW Horby, G Pessoa-Amorim, L Peto, CE Brightling, R Sarkar, K Thomas, ... Medrxiv, 2021 | 299 | 2021 |
| Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10274), 605, 2021 | 211 | 2021 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 399 (10325), 665-676, 2022 | 76 | 2022 |
| Performance of intensive care unit severity scoring systems across different ethnicities in the USA: a retrospective observational study R Sarkar, C Martin, H Mattie, JW Gichoya, DJ Stone, LA Celi The Lancet Digital Health 3 (4), e241-e249, 2021 | 56 | 2021 |
| Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 399 (10320), 143-151, 2022 | 45 | 2022 |
| Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial PW Horby, G Pessoa-Amorim, N Staplin, JR Emberson, M Campbell, ... The Lancet 399 (10320), 143-151, 2021 | 34 | 2021 |
| FDA approved L-type channel blocker Nifedipine reduces cell death in hypoxic A549 cells through modulation of mitochondrial calcium and superoxide generation K Manohar, RK Gupta, P Gupta, D Saha, S Gare, R Sarkar, A Misra, L Giri Free Radical Biology and Medicine 177, 189-200, 2021 | 11 | 2021 |
| Construction of a demand and capacity model for intensive care and hospital ward beds, and mortality from COVID-19 C Martin, S McDonald, S Bale, M Luteijn, R Sarkar BMC medical informatics and decision making 21 (1), 138, 2021 | 9 | 2021 |
| An ML prediction model based on clinical parameters and automated CT scan features for COVID-19 patients A Sinha, SP Joshi, PS Das, S Jana, R Sarkar Scientific Reports 12 (1), 11255, 2022 | 7 | 2022 |
| Effect of routine fiberoptic bronchoscopy and bronchoalveolar lavage on arterial blood gases. SK Sharma, JN Pande, R Sarkar The Indian Journal of Chest Diseases & Allied Sciences 35 (1), 3-8, 1993 | 7 | 1993 |
| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): preliminary results of a randomised, controlled, open-label, platform trial. medRxiv. 2021: 2021.02. 11 … PW Horby, G Pessoa-Amorim, L Peto, CE Brightling, R Sarkar, K Thomas Remdesivir given, 16, 0 | 7 | |
| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): preliminary results of a randomised, controlled, open-label, platform trial. medRxiv 2021.02. 11.21249258 RECOVERY Collaborative Group, PW Horby, G Pessoa-Amorim, L Peto, ... | 5 | 2021 |
| RECOVERY Collaborative Group Tocilizumab in Patients Admitted to Hospital with COVID-19 (RECOVERY): Preliminary Results of a Randomised, Controlled, Open-Label, Platform Trial PW Horby, G Pessoa-Amorim, L Peto, CE Brightling, R Sarkar, K Thomas, ... MedRxiv, 2021 | 4 | 2021 |
| Three-dimensional tracking of intracellular calcium and redox state during real-time control in a hypoxic gradient in microglia culture: Comparison of the channel blocker and … V Dhyani, S Kumar, SR Manne, I Kaur, S Jana, S Russell, R Sarkar, L Giri ACS Chemical Neuroscience 14 (10), 1810-1825, 2023 | 2 | 2023 |
| Automated quantification of inflamed lung regions in chest CT by UNET++ and SegCaps: a comparative analysis in COVID-19 cases P Bhatia, A Sinha, SP Joshi, R Sarkar, R Ghosh, S Jana 2022 44th Annual International Conference of the IEEE Engineering in …, 2022 | 2 | 2022 |
| Analytics Pipeline for Visualization of Single Cell RNA Sequencing Data from Brochoaveolar Fluid in COVID-19 Patients: Assessment of Neuro Fuzzy-C-Means and HDBSCAN S Gare, S Chel, PD Pantula, A Saxena, K Mitra, R Sarkar, L Giri 2022 44th Annual International Conference of the IEEE Engineering in …, 2022 | 2 | 2022 |
| Performance of intensive care unit severity scoring systems across different ethnicities R Sarkar, C Martin, H Mattie, JW Gichoya, DJ Stone, LA Celi medRxiv, 2021 | 2 | 2021 |
| Computational framework to understand the clinical stages of COVID‐19 and visualization of time course for various treatment strategies S Sharma, R Sarkar, K Mitra, L Giri Biotechnology and Bioengineering 120 (6), 1640-1656, 2023 | 1 | 2023 |
